Development of contractile dysfunction in rat heart failure: Hierarchy of cellular events

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 1, 2007, Pages

  Daniels, Marcel C G ^a,b   Naya, Taihei ^a   Rundell, Veronica L M ^a   De Tombe, Pieter P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Calcium; Cross bridges; Laser diffraction; Myofibrillar proteins; Myofilaments; Myosin ATPase; Sarcomere mechanics

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATE; CALCIUM ION; PHOSPHOLAMBAN; RYANODINE RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HYDROLYSIS; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SENSITIVITY ANALYSIS;

ALGORITHMS; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CARDIAC OUTPUT, LOW; FEMALE; HOMEOSTASIS; MICROFILAMENTS; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOSIN HEAVY CHAINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SARCOMERES; TRABECULAR MESHWORK;

EID: 34447631468     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00880.2006     Document Type: Article

References (47)

1. 2+ leak in heart failure. Circ Res 97: 1314-1322, 2005.
2. Alpert NR, Gordon MS. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 202: 940-946, 1962.
3. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469, 1993.
4. 2+] in intact rat cardiac trabeculae. J Gen Physiol 105: 1-19, 1995.
5. Belin RJ, Sumandea MP, Kobayashi T, Walker LA, Rundell VL, Urboniene D, Yuzhakova M, Ruch SH, Geenen DL, Solaro RJ, de Tombe PP. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol 291: H2344-H2353, 2006.
6. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, Dordrecht, The Netherlands: Kluwer Academic, 2001.
7. Daniels MCG, Keller RS, de Tombe PP. Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction. Am J Physiol Heart Circ Physiol 281: H2150-H2158, 2001.
8. de Tombe PP. Altered contractile function in heart failure. Rev Cardiovasc Res 37: 367-380, 1998.
9. de Tombe PP, Stienen GJ. Protein kinase A does not alter economy of force maintenance in skinned rat cardiac trabeculae. Circ Res 76: 734-741, 1995.
10. de Tombe PP, Wannenburg T, Fan D, Little WC. Right ventricular contractile protein function in rats with left ventricular myocardial infarction. Am J Physiol Heart Circ Physiol 271: H73-H79, 1996.
11. Dixon IMC, Hata T, Dhalla NS. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol Heart Circ Physiol 262: H1387-H1394, 1992.
12. Evans CC, Walker LA, Rundell VL, George T, Pappas PS, de Tombe PP, Slaughter MS. Mechanical support normalizes myofilament forceatpase relationship in heart failure (Abstract). Circulation 108: 15, 2004.
13. Fan D, Wannenburg T, de Tombe PP. Decreased myocyte tension development and calcium responsiveness in rat right ventricular pressure overload. Circulation 95: 2312-2317, 1997.
14. Fitzsimons DP, Patel JR, Moss RL. Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium. J Physiol 513: 171-183, 1998.
15. 2+ exchanger in failing human myocardium. Circulation 94: 992-1002, 1996.
16. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276: 800-806, 1997.
17. 2+ in intact and skinned tyrabeculae from control and myopathic human hearts. J Clin Invest 82: 1578-1584, 1988.
18. Hambleton M, Hahn H, Pleger ST, Kuhn MC, Klevitsky R, Carr AN, Kimball TF, Hewett TE, Dorn GW, 2nd Koch WJ, Molkentin JD. Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation 114: 574-582, 2006.
19. Harris DE, Work SS, Wright RK, Alpert NR, Warshaw DM. Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J Muscle Res Cell Motil 15: 11-19, 1994.
20. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37: 279-289, 1998.
21. Herron TJ, Korte FS, McDonald KS. Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 281: H1217-H1222, 2001.
22. Jweied EE, McKinney RD, Walker LA, Brodsky I, Geha AS, Massad MG, Buttrick PM, de Tombe PP. Depressed cardiac myofilament function in human diabetes mellitus. Am J Physiol Heart Circ Physiol 289: H2478-H2483, 2005.
23. Kobayashi T, Solaro RJ. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol 67: 39-67, 2005.
24. 2+ exchange in the infarcted heart. Implications for excitation-contraction coupling. Circ Res 81: 1083-1093, 1997.
25. Martin AF, Phillips RM, Kumar A, Crawford K, Abbas Z, Lessard JL, De Tombe P, Solaro RJ. Ca(2+) activation and tension cost in myofilaments from mouse hearts ectopically expressing enteric gammaactin. Am J Physiol Heart Circ Physiol 283: H642-H649, 2002.
26. Meyer M, Schillenger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995.
27. Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 86: 386-390, 2000.
28. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation 85: 1743-1750, 1992.
29. Narolska NA, van Loon RB, Boontje NM, Zaremba R, Penas SE, Russell J, Spiegelenberg SR, Huybregts MA, Visser FC, de Jong JW, van der Velden J, Stienen GJ. Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue. Cardiovasc Res 65: 221-229, 2005.
30. Pagani ED, Alousi AA, Grant AM, Older TM, Dziuban SW, Allen PD. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissue from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res 63: 380-385, 1988.
31. Pathak A, del Monte F, Zhao W, Schultz JE, Lorenz JN, Bodi I, Weiser D, Hahn H, Carr AN, Syed F, Mavila N, Jha L, Qian J, Marreez Y, Chen G, McGraw DW, Heist EK, Guerrero JL, DePaoli-Roach AA, Hajjar RJ, Kranias EG. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res 96: 756-766, 2005.
32. Perez NG, Hashimoto K, McCune S, Altschuld RA, Marban E. Origin of contractile dysfunction in heart failure: calcium cycling vs. myofilaments. Circulation 99: 1077-1083, 1999.
33. Piacentino V, 3rd Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM, Houser SR. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 92: 651-658, 2003.
34. Ruf T, Schulte-Baukloh H, Ludemann J, Posival H, Beyersdorf F, Just H, Holubarsch C. Alterations of cross-bridge kinetics in human atrial and ventricular myocardium. Cardiovasc Res 40: 580-590, 1998.
35. Rundell VL, Geenen DL, Buttrick PM, de Tombe PP. Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 287: H408-H413, 2004.
36. Rundell VL, Manaves V, Martin AF, de Tombe PP. Impact of betamyosin heavy chain isoform expression on cross-bridge cycling kinetics. Am J Physiol Heart Circ Physiol 288: H896-H903, 2005.
37. Sah R, Ramirez RJ, Kaprielian R, Backx PH. Alterations in action potential profile enhance excitation-contraction coupling in rat cardiac myocytes. J Physiol 533: 201-214, 2001.
38. 2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995.
39. 2+ exchanger protein levels in human heart failure. Circulation 99: 2105-2112, 1999.
40. Sumandea MP, Burkart EM, Kobayashi T, De Tombe PP, Solaro RJ. Molecular and integrated biology of thin filament protein phosphorylation in heart muscle. Ann NY Acad Sci 1015: 39 -52, 2004.
41. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 278: 35135-35144, 2003.
42. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscle. Physiol Rev 66: 710-771, 1986.
43. van der Velden J, Moorman AF, Stienen GJ. Age-dependent changes in myosin composition correlate with enhanced economy of contraction in guinea-pig hearts. J Physiol 507: 497-510, 1998.
44. 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 57: 37-47, 2003.
45. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci USA 103: 511-518, 2006.
46. Wickenden AD, Kaprielian R, Kassiri Z, Tsoporis JN, Fishman GI, Backx PH. The role of action potential prolongation and altered calcium handling in the pathogenesis of heart failure. Cardiovasc Res 37: 312-323, 1998.
47. 2+ channel, GRK2, and phosphorylated phospholamban: protective mechanisms for the denervated failing heart. J Mol Cell Cardiol 40: 619-628, 2006.